William Osler Health System
11
2
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
9%
1 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Pan-Canadian Lung Cancer Observational Study (PALEOS)
Role: lead
Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care
Role: collaborator
PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL)
Role: collaborator
Evaluation of Nurse-led Integrated Care of Complex Patients Facilitated By Telemonitoring: The SMaRT Study
Role: collaborator
Implementation of RELIEF for Patients With Palliative Care Needs
Role: lead
Clinical Surveillance Tool to Screen for Unmet Palliative Needs Among Patients in the Final Year of Life
Role: collaborator
Prone Positioning for Patients on General Medical Wards With COVID19
Role: collaborator
Mental Health Outcomes in Healthcare Workers During COVID-19
Role: collaborator
Access in Dialysis for Better Outcomes in Patient Therapy
Role: lead
Field Implementation of the autoRIC Device in STEMI
Role: lead
Evaluate the Value of Telehomecare for Diabetes
Role: collaborator
All 11 trials loaded